Exscientia PLC (EXAI) - Cash on Hand per Share

Corporate emblem and logo of Exscientia (EXAI)

Exscientia plc (EXAI) is fighting for leadership in the algorithmic race by implementing robotic compound synthesis powered by Centaur Chemist. Analyzing the cash per share metric, it is evident that the 2.48 mark serves as a key figure for assessing financial stability. The application of AI in pharmacology minimizes the consumption of plastics and chemical reagents, ensuring high production sustainability.

Exscientia Inc. - EXAI Cash per Share (period 07/04/2022 - 11/30/2024)

Comprehensive metric breakdowns and analytics for Exscientia Inc. (EXAI)

- stock value and consensus price forecast:
- cash position and cash flow details:
Summary company analysis:Exscientia plc
Manufactured product of Exscientia PLC

Exscientia plc (EXAI) is developing a cloud-based AI infrastructure for drug discovery, where capacity scaling occurs via software without physical wear and tear. The cash_on_share metric measures specific liquidity by comparing total cash reserves to the number of shares outstanding. This allows an investor to assess the business's financial stability or identify inefficient capital accumulation. The current value of 2.48 reflects the available resource per share. Analyzing the issuer's cash per share helps determine the equilibrium point between crisis protection and growth potential.